about
sameAs
Methods for identifying 30 chronic conditions: application to administrative data.Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis.Validation of a case definition to define chronic dialysis using outpatient administrative dataValidating a case definition for chronic kidney disease using administrative data.Population based screening for chronic kidney disease: cost effectiveness study.Relation between kidney function, proteinuria, and adverse outcomes.The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.Residence location and likelihood of kidney transplantationAssociations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes.Trace element supplementation in hemodialysis patients: a randomized controlled trialCost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular riskAdding specialized clinics for remote-dwellers with chronic kidney disease: a cost-utility analysis.The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trialA cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysisCause of Death in Patients with Reduced Kidney Function.Kidney stones and kidney function loss: a cohort studyAssociation between AKI, recovery of renal function, and long-term outcomes after hospital dischargeRelation between access blood flow and mortality in chronic hemodialysis patients.Association between LDL-C and risk of myocardial infarction in CKDQuality of care among Aboriginal hemodialysis patients.Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.Quality of care for First Nations and non-First Nations People with diabetes.Factors associated with initiation of chronic renal replacement therapy for patients with kidney failureUltrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review.Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuriaEconomic evaluation of continuous renal replacement therapy in acute renal failure.What's next after fistula first: is an arteriovenous graft or central venous catheter preferable when an arteriovenous fistula is not possible?Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis.Kidney stones and cardiovascular events: a cohort study.Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trialsCardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis.Financial aspects of renal replacement therapy in acute kidney injury.Use of administrative databases for health-care planning in CKD.Age and treatment of kidney failure.Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies.Multimorbidity, dementia and health care in older people:a population-based cohort studyArteriovenous fistula survival and needling technique: long-term results from a randomized buttonhole trial.Impact of age on the association between CKD and the risk of future coronary events.
P50
Q30935606-E306861C-A3B7-40A3-A29A-B7FBB692D95AQ33615328-2AF9464E-DA10-49DC-A657-AE1451DE1105Q33833164-4E25EDD8-984C-4AB5-BCC3-72751AF0AE29Q34052928-C9A689F0-F1D0-4144-A6DB-288156D97AC0Q34286311-A0AC4931-0F02-44E3-A349-84604371C2EEQ34659683-4BDA7DD0-B2A1-4D54-8FDF-66A1C3FDE1FCQ34765075-387E1909-69A7-472B-96E3-E170549C73CCQ34769989-3477F5E4-3E8D-458D-B61F-931D61271ABDQ34998973-3ED1D687-0276-413B-9310-22F47CA0001BQ35030639-E5F7CDA9-B14C-4B71-A57A-88244230F29BQ35538138-AA8476A2-E21B-4829-B28D-C7C01861591DQ35551084-7E83C0AB-3800-44A6-9CB8-464AA3797AB6Q35692458-99812244-CA8E-4FF2-9044-51C67E93C2D5Q35754027-453E2B0B-0B76-45EC-9AA4-1FF51FD1FA7AQ35860695-956FAEFE-3732-4B69-9697-894A0CBCBA73Q36069573-35FA2144-A244-445C-8BFE-C2A2A2BAAA23Q36104829-3B06D0BF-8BD0-41F5-B351-8076E5BC8FBEQ36201055-A0971F50-DAC8-4C94-9A3E-6236346FACFAQ36583373-D2796EA0-64B0-45F8-9412-FFCF8FB42103Q36666745-EEEBBF84-1265-4F87-9A1A-9882E794C093Q36880435-E6BAB821-81D9-4ACA-A1A9-13B4716AC2EAQ36910288-4E4E59DE-0F9E-4E6F-AA51-4943AD5EFAB3Q36955966-01CAED84-45EB-46E4-805C-506D07B2ABA1Q36980354-8DF860A4-126A-4A65-88E1-D1532F78C814Q37065624-4945118B-3CD0-4ADA-8D13-597E295C4816Q37121114-6B2F8824-41EA-42D8-9161-0BC63808CA46Q37521514-BC0F323B-27ED-4422-9AD8-803484EE570BQ37556688-E31EA54D-B0A5-440B-9854-B8912A43E871Q37594864-EF5DCCA0-2879-43CE-884B-29F27F2D7198Q37603998-31301B6D-3EF6-468B-9617-8BED95EA0A69Q37621543-1B02DEDF-1E29-4AA5-AA51-494B6E2A1733Q37677470-63AC7B68-AE8C-4F5B-ACD0-F0896DD6764AQ37687693-7743A1B1-00DF-4261-9CF3-D14EDD64D512Q37868697-AEA45781-AFFF-4961-BB4F-FDF86EFA5988Q38021777-75AD7B41-099C-474C-A36A-792DDD8911E5Q38085991-81F59EEE-014A-407B-8785-574725841A9FQ38217484-5F067DD8-7A03-4144-8209-9A46421B0E5BQ38623214-A5819E9F-7BF2-4747-BA8F-AE98FA925069Q39200092-750D8487-336D-43BC-A308-4B60B43CE4EFQ39206414-77B5C940-F71F-4C58-9750-3FA03FDF825D
P50
description
Einrichtung in Kanada
@de
facility in Edmonton, Canada
@en
name
Alberta Kidney Disease Network
@en
type
label
Alberta Kidney Disease Network
@en
altLabel
AKDN
@en
prefLabel
Alberta Kidney Disease Network
@en
P17
P2427
grid.497602.e
P625
Point (-113.493974 53.546983)